CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery - Wikidata - wikimedia - TriplyDB

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

http://www.wikidata.org/entity/Q28256367

about

The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.More than markers: biological significance of cancer stem cell-defining molecules.NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.Clinical implications of cancer stem cell biology in hepatocellular carcinoma.Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.Hepatocellular carcinoma: insight from animal models.CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34a.Contractile forces contribute to increased glycosylphosphatidylinositol-anchored receptor CD24-facilitated cancer cell invasion.Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma.CD24 expression as a marker for predicting clinical outcome in human gliomas.Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity Clinical value of CD24 expression in retinoblastoma.Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo.CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma CD24 genetic variants contribute to overall survival in patients with gastric cancer.CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.Gene-expression signature of vascular invasion in hepatocellular carcinoma.ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma.Cancer stem cells as a potential therapeutic target in breast cancer Loss of exon 4 in a human T-cell factor-4 isoform promotes hepatic tumourigenicity.Membranous CD24 drives the epithelial phenotype of pancreatic cancer.Attenuated Listeria monocytogenes as a cancer vaccine vector for the delivery of CD24, a biomarker for hepatic cancer stem cells.Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.Biomarkers for predicting future metastasis of human gastrointestinal tumors.Oncolytic and immunotherapeutic vaccinia induces antibody-mediated complement-dependent cancer cell lysis in humans.Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment.Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma.Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer.An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma.Low expression of DCXR protein indicates a poor prognosis for hepatocellular carcinoma patients.

P2860

Q28071619-86EAB96E-C7E6-4710-B629-7FBC0F97A343 Q28546911-C0F9DB25-A885-4F8A-B9C6-0D52C7573CE8 Q30408689-30B5921A-0180-40DF-ACA1-8147784D1FA3 Q33661278-F9C67F21-C119-474A-AE3E-84A3F8FB1714 Q33933777-E4100BA5-F6D4-4516-891A-CD07F97E2311 Q34246526-DC6B08F6-413D-477E-8B1E-8F3DA6F32620 Q34357073-536B4708-67DF-40C7-818F-C974E5CB937B Q34416873-09CAF1F5-377C-4C24-9482-F33A777AD175 Q34633249-C7858DA0-21BD-4C00-9EA6-8A578BC0755F Q34637872-2068AEF8-4B63-4F77-90E0-6B0A5D923210 Q35266736-80809501-6621-49A1-B6FB-7CC489E7DB66 Q35561267-7C613206-0F74-46A5-A037-DB14039F86A7 Q35745018-F2948B1C-5CFA-45FC-A84E-B857A396957C Q35830525-73FDCA62-4A8D-4045-A8B6-B822CA8936F1 Q36014411-63AE9E71-DAA7-4AAB-8D7F-99ECCE557190 Q36056192-3D8731B0-7828-4D3A-B0D2-AE2A56EA4BA7 Q36378949-D16713CA-D70D-4B74-B8B0-1BF4D0780A70 Q36525387-23289C57-4C5D-4691-9BE0-3555E617EDE9 Q36526362-F5F5C338-453B-491B-A965-1025F4A545D5 Q36699282-06437D0A-F0BD-4CBC-8070-737DBCE3A031 Q36759564-93A62E52-81C1-478C-9538-310AD7AA1233 Q36866385-58A5FE4E-6EF5-4DC4-9D6D-3224298ACA45 Q37043792-E6F541CD-518A-4821-B793-5346530D09DF Q37179096-AE1FDACF-7C93-4D39-8C6E-FDC0C08C21AF Q37580189-C0530CB2-E501-469C-8BD1-C8AD483CDD82 Q37729987-F37B9D9C-A41D-4DF9-A582-BD3587CDE3F6 Q37978771-D4BDF518-186A-4C76-9090-360278854804 Q38078237-891178A7-81FB-426D-9C49-9D966395723F Q38450392-234D144D-27A0-4442-8F05-91BD52BFA9E9 Q38466472-49EFFDCB-CBDB-42FE-AF6B-E632259839BB Q38814227-19CF339E-3421-416F-9413-6E97323044DB Q38816567-D0EDFE4A-3F46-4646-8C69-C0852F6249A9 Q39010236-8C4625DA-31A0-415B-B3C3-EEE68B05AE33 Q39023964-DC5301FB-EA7F-4918-A9CF-FCA900AFBBBB Q39248557-8D988ECE-C540-491A-B84D-CC3F47B3C639 Q39310276-D3140A84-7186-4A9D-8859-47EEEE5291EC Q39465495-40EDFDA9-B95B-4EC9-A22A-B3FB0A7571CF Q39473996-5CB4450D-0DFE-40E9-9F80-C8C906EDCF49 Q39643637-23C1C449-3D61-469D-A635-8A2EFB4F1587 Q40530495-FB3D1D9C-34AB-4438-9E71-B2F3A3989DF3

P2860

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

http://www.wikidata.org/entity/Q28256367

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@ast

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@en

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@nl

type

label

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@ast

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@en

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@nl

prefLabel

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@ast

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@en

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@nl

P1433

Q28256367-B4D8D031-A064-46BB-9DDB-D51C92A4127A

P1476

Q28256367-186FC5F5-7609-4443-BE4E-74A9DA87C9E8

P2093

Q28256367-0864E999-3BE1-47D9-8553-6BE47BEE1176

Q28256367-18C441FB-0DBF-4B0B-B4D7-66BD31D7EC90

Q28256367-43B3B1A2-69AA-414F-B1CC-0EDD3C4BF14C

Q28256367-4A0D8F87-58E4-4BE9-90B6-A6FCB5B464D3

Q28256367-64D7D304-E7D0-43A8-A83F-7F3F08654B4B

Q28256367-701EF375-BE44-4051-9842-C423B832CCD8

Q28256367-84374DFB-4460-4286-B268-DCB3923BA835

Q28256367-9DC02FE6-150A-4DED-8E97-E2EFE065117D

Q28256367-A14B407E-1A3D-47C1-B12A-56CA3104CB1D

Q28256367-AC1133A2-E9B1-414A-89A5-29DE1ED1F129

P304

Q28256367-70BCC8F0-1C37-45CE-8493-FD84F72F4C61

P31

Q28256367-35C095C4-DAF5-4CCB-9655-00D141D4E300

P3181

Q28256367-A780668E-02EE-4F21-91BF-84201CDBC331

P356

Q28256367-93C837EC-1965-4BA9-ACB3-790290322976

P407

Q28256367-0AC723DD-AA30-4087-A1CB-1B15FD549872

P433

Q28256367-34A129F4-1ADA-4E77-B46B-01B481A1C58A

P478

Q28256367-5639835F-17A4-4174-A704-0CE836AE058E

P577

Q28256367-2FDE3DBF-F7AF-4578-BAE9-9BF3B8937725

P698

Q28256367-9BDE8207-1FA6-4884-BDC1-ED78B15EB734

P3181

P356

1078-0432.CCR-09-0151

P1433

Clinical Cancer Research

P1476

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery

@en

P2093

Bin Wu

http://www.w3.org/2001/XMLSchema#string

Bin Yu

http://www.w3.org/2001/XMLSchema#string

Bo-Heng Zhang

http://www.w3.org/2001/XMLSchema#string

Guo-Huan Yang

http://www.w3.org/2001/XMLSchema#string

Guo-Ming Shi

http://www.w3.org/2001/XMLSchema#string

Jia Fan

http://www.w3.org/2001/XMLSchema#string

Jia-Chu Li

http://www.w3.org/2001/XMLSchema#string

Jian Zhou

http://www.w3.org/2001/XMLSchema#string

Li-Ming Wu

http://www.w3.org/2001/XMLSchema#string

Shuang-Jian Qiu

http://www.w3.org/2001/XMLSchema#string

P304

5518-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4033601

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/1078-0432.CCR-09-0151

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19706825

http://www.w3.org/2001/XMLSchema#string